Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elai Davicioni

Showing results (11-20 of 273) with videos related to

Pageof 28
Sort By:
Breast Cancer Research and Treatment|December 3, 2011
Progression of ductal carcinoma in situ to invasive breast cancer is associated with gene expression programs of EMT and myoepitheliaErik S Knudsen, Adam Ertel, Elai Davicioni, et al.
European Urology|July 7, 2014
Combined value of validated clinical and genomic risk stratification tools for predicting prostate cancer mortality in a high-risk prostatectomy cohortMatthew R Cooperberg, Elai Davicioni, Anamaria Crisan, et al.
Journal of Cancer Research and Clinical Oncology|April 17, 2021
Expression of ISL1 and its partners in prostate cancer progression and neuroendocrine differentiationMohammed Alshalalfa, Hatem Abou-Ouf, Elai Davicioni, et al.
The Journal of Pathology|June 18, 2019
Development of a predictive model for stromal content in prostate cancer samples to improve signature performanceNadia Boufaied, Mandeep Takhar, Claire Nash, et al.
Urology|October 29, 2017
Gene Expression Correlates of Site-specific Metastasis Among Men With Lymph Node Positive Prostate Cancer Treated With Radical Prostatectomy: A Case SeriesVidit Sharma, Kasra Yousefi, Zaid Haddad, et al.
Cancer Research|July 20, 2006
Identification of a PAX-FKHR gene expression signature that defines molecular classes and determines the prognosis of alveolar rhabdomyosarcomasElai Davicioni, Friedrich Graf Finckenstein, Violette Shahbazian, et al.
Journal of the National Cancer Institute|July 12, 2007
Histone deacetylase 1 gene expression and sensitization of multidrug-resistant neuroblastoma cell lines to cytotoxic agents by depsipeptideNino Keshelava, Elai Davicioni, Zesheng Wan, et al.
European Urology Open Science|February 6, 2023
Prostate Cancer Tumor Volume and Genomic RiskAshwin Ramaswamy, James A Proudfoot, Ashley E Ross, et al.
Transgenic Research|September 5, 2006
Transgenic mice expressing PAX3-FKHR have multiple defects in muscle development, including ectopic skeletal myogenesis in the developing neural tubeFriedrich Graf Finckenstein, Elai Davicioni, Kent G Osborn, et al.
Urology|July 4, 2020
Predictors of Prostate-specific Membrane Antigen (PSMA/FOLH1) Expression in a Genomic DatabaseClinton D Bahler, Melissa M Johnson, Elai Davicioni, et al.
Pageof 28

Showing results (11-20 of 273) with videos related to

Sort By:
Pageof 28
Breast Cancer Research and Treatment|December 3, 2011
Progression of ductal carcinoma in situ to invasive breast cancer is associated with gene expression programs of EMT and myoepitheliaErik S Knudsen, Adam Ertel, Elai Davicioni, et al.
European Urology|July 7, 2014
Combined value of validated clinical and genomic risk stratification tools for predicting prostate cancer mortality in a high-risk prostatectomy cohortMatthew R Cooperberg, Elai Davicioni, Anamaria Crisan, et al.
Journal of Cancer Research and Clinical Oncology|April 17, 2021
Expression of ISL1 and its partners in prostate cancer progression and neuroendocrine differentiationMohammed Alshalalfa, Hatem Abou-Ouf, Elai Davicioni, et al.
The Journal of Pathology|June 18, 2019
Development of a predictive model for stromal content in prostate cancer samples to improve signature performanceNadia Boufaied, Mandeep Takhar, Claire Nash, et al.
Urology|October 29, 2017
Gene Expression Correlates of Site-specific Metastasis Among Men With Lymph Node Positive Prostate Cancer Treated With Radical Prostatectomy: A Case SeriesVidit Sharma, Kasra Yousefi, Zaid Haddad, et al.
Cancer Research|July 20, 2006
Identification of a PAX-FKHR gene expression signature that defines molecular classes and determines the prognosis of alveolar rhabdomyosarcomasElai Davicioni, Friedrich Graf Finckenstein, Violette Shahbazian, et al.
Journal of the National Cancer Institute|July 12, 2007
Histone deacetylase 1 gene expression and sensitization of multidrug-resistant neuroblastoma cell lines to cytotoxic agents by depsipeptideNino Keshelava, Elai Davicioni, Zesheng Wan, et al.
European Urology Open Science|February 6, 2023
Prostate Cancer Tumor Volume and Genomic RiskAshwin Ramaswamy, James A Proudfoot, Ashley E Ross, et al.
Transgenic Research|September 5, 2006
Transgenic mice expressing PAX3-FKHR have multiple defects in muscle development, including ectopic skeletal myogenesis in the developing neural tubeFriedrich Graf Finckenstein, Elai Davicioni, Kent G Osborn, et al.
Urology|July 4, 2020
Predictors of Prostate-specific Membrane Antigen (PSMA/FOLH1) Expression in a Genomic DatabaseClinton D Bahler, Melissa M Johnson, Elai Davicioni, et al.
Pageof 28